8-Methoxypsoralen

규격

298-81-7CAS 번호

206-066-9EC 번호

9-methoxyfuro[3,2-g]chromen-7-oneIUPAC 명칭

C12H8O4화학식

216.19 g/mol분자량

methoxsalen; 8-Methoxypsoralen; 298-81-7; XANTHOTOXIN; Meladinine; Oxsoralen; 8-MOP; 9-Methoxy-7H-furo[3,2-g]chromen-7-one; Oxypsoralen; Meloxine; Puvalen; Xanthotoxine; Ammoidin; Meladinin; Uvadex; Meladoxen; Ammodin; 8-Methoxypsoralene; New-Meladinin; Geroxalen; Zanthotoxin; Puvamet; Psoralon-MOP; 9-Methoxypsoralen; Oxsoralen Ultra; 8-Methoxyfuranocoumarin; 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one; O-methylxanthotoxol; Vitpso; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-; Ultra Mop; 8-Methoxy-2',3',6,7-furocoumarin; Metoxalen; Metoxaleno; NCI-C55903; 8-methoxsalen; 8-Methoxy-4',5',6,7-furocoumarin; DTXSID8020830; NSC45923; 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone; 8-Methoxy-4',5':6,7-furocoumarin; 7H-Furo(3,2-G)(1)benzopyran-7-one, 9-methoxy-; 8-Methoxy-(furano-3'.2':6.7-coumarin); 8-Methoxy-[furano-3'.2':6.7-coumarin]; U4VJ29L7BQ; NSC-45923; 9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; CHEBI:18358; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone; DTXCID40830; SM-88 COMPONENT METHOXSALEN; Methoxa Dome; 8 Methoxypsoralen; methoxypsoralen; 8MOP; 9-methoxy-7H-furo(3,2-g)chromen-7-one; 8 MOP; Mopsoralen; Puvasoralen; Puvasoralen-8; RefChem:41982; 8-Methoxy(furano-3',2':6,7-coumarin); Methoxa-Dome; Oxsoralen-ultra; Methoxalen; Oxsoralen lotion; 8-MP; 9-methoxyfuro[3,2-g]chromen-7-one; Methoxy-8-psoralen; 8-methoxy psoralen; MFCD00005009; NSC 45923; Methoxsalen (Oxsoralen); 9-Methoxyfuro(3,2-g)chromen-7-one; CHEMBL416; 9-(methyloxy)-7H-furo[3,2-g]chromen-7-one; Proralone-mop; 9-methoxyfurano[3,2-g]chromen-2-one; Meladinin (VAN); NCGC00016418-07; CAS-298-81-7; Methoxaten; Oxoralen; ST041029; Deltapsoralen; Dltasoralen; Methoxsalene; Xanthatoxin; Methoxsalen, 8-; SMR000071170; CCRIS 2083; HSDB 2505; 8-Methoxypsoralen with ultraviolet A therapy; OXSORALEN (TN); SR-01000629727; EINECS 206-066-9; Methoxsalen plus ultraviolet radiation; UNII-U4VJ29L7BQ; BRN 0196453; Methoxsalen [USP:BAN:JAN]; 9-Methoxy-7H-furo(3,2-g)benzopyran-7-one; 8-methoxylpsoralen; Prestwick_661; Xanthotoxin,Methoxsalen; Methoxsalen (Standard); Spectrum_001023; 8-Methoxy(furano-3'.2':6.7-coumarin); METHOXSALEN [MI]; Prestwick0_000479; Prestwick1_000479; Prestwick2_000479; Prestwick3_000479; Spectrum2_001052; Spectrum3_000499; Spectrum4_000052; Spectrum5_001891; METHOXSALEN [JAN]; UVADEX (TN); Xanthotoxin (Methoxsalen); X0009; METHOXSALEN [HSDB]; METHOXSALEN [IARC]; Epitope ID:613448; Methoxsalen (JP18/USP); METHOXSALEN [VANDF]; 7H-Furo[3, 9-methoxy-; METHOXSALEN [MART.]; Oprea1_166319; SCHEMBL19168; BSPBio_000618; BSPBio_001997; KBioGR_000543; KBioSS_001503; METHOXSALEN [USP-RS]; METHOXSALEN [WHO-DD]; 5-19-06-00015 (Beilstein Handbook Reference); 8MO; MLS000062633; MLS002303011; DivK1c_000763; SPECTRUM1500400; SPBio_001004; SPBio_002557; 8-Methoxy-6,7-furanocoumarin; BPBio1_000680; MEGxp0_000095; orb1225399; orb2281208; orb3025346; Xanthotoxin, analytical standard; 8-Methoxypsoralen (Xanthotoxin); SCHEMBL29376525; ACon1_000174; GTPL12457; HMS502G05; KBio1_000763; KBio2_001503; KBio2_004071; KBio2_006639; KBio3_001497; METHOXSALEN [ORANGE BOOK]; 8-Methoxy-2',6,7-furocoumarin; 8-Methoxy-4',6,7-furocoumarin; NINDS_000763; HMS1569O20; HMS1920N05; HMS2091D20; HMS2096O20; HMS2269P03; HMS3259L13; HMS3655B05; HMS3884K16; HMS5080L07; Pharmakon1600-01500400; METHOXSALEN [USP MONOGRAPH]; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone; Tox21_110432; Tox21_201767; Tox21_302816; 8-Methoxypsoralen;Xanthotoxin;8-MOP; BDBM50041234; CCG-36366; EBC-11074; HY-30151R; NSC757114; s1952; SBB005950; STK735539; WLN: T C566 DO LVOJ BO1; 8-Methoxypsoralen, analytical standard; AKOS000277012; Tox21_110432_1; 9-Methoxy-furo[3,2-g]chromen-7-one; AC-4259; CS-1983; DB00553; DS-5159; FM08242; METHOXSALEN COMPONENT OF SM-88; NC00652; NSC-757114; SDCCGMLS-0042377.P002; IDI1_000763; 8-methoxy-2'',3'',6,7-furocoumarin; 8-methoxy-4'',5'':6,7-furocoumarin; NCGC00016418-01; NCGC00016418-02; NCGC00016418-03; NCGC00016418-04; NCGC00016418-05; NCGC00016418-06; NCGC00016418-08; NCGC00016418-09; NCGC00016418-10; NCGC00016418-11; NCGC00016418-12; NCGC00016418-14; NCGC00016418-15; NCGC00016418-22; NCGC00060938-02; NCGC00060938-03; NCGC00060938-04; NCGC00060938-05; NCGC00060938-06; NCGC00178871-01; NCGC00178871-02; NCGC00178871-03; NCGC00256435-01; NCGC00259316-01; HY-30151; NCI60_004085; SBI-0051443.P003; NS00004875; SW167762-4; 8-methoxy-[furano-3''.2'':6.7-coumarin]; 9-Methoxy-7H-furo[3,2-g]chromen-7-one #; EN300-52504; C01864; D00139; AB00052042-14; AB00052042-15; AB00052042_16; AB00052042_17; 9-METHOXY-2H-FURO[3,2-G]CHROMEN-2-ONE; AH-357/03514063; F239129; Q408570; SR-01000629727-2; SR-01000629727-4; BRD-K63430059-001-03-2; BRD-K63430059-001-06-5; BRD-K63430059-001-09-9; BRD-K63430059-001-16-4; BRD-K63430059-001-17-2; Z754918916; Methoxsalen, United States Pharmacopeia (USP) Reference Standard; 12692-94-3동의어